Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib

por Yamamoto, Naoki, Yamasaki, Takahiro, Takami, Taro, Uchida, Koichi, Fujisawa, Koichi, Matsumoto, Toshihiko, Saeki, Issei, Terai, Shuji, Sakaida, Isao
Publicado 2016

A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy

por Saeki, Issei, Yamasaki, Takahiro, Tanabe, Norikazu, Iwamoto, Takuya, Matsumoto, Toshihiko, Urata, Yohei, Hidaka, Isao, Ishikawa, Tsuyoshi, Takami, Taro, Yamamoto, Naoki, Uchida, Koichi, Terai, Shuji, Sakaida, Isao
Publicado 2015

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma

por Saeki, Issei, Yamamoto, Naoki, Yamasaki, Takahiro, Takami, Taro, Maeda, Masaki, Fujisawa, Koichi, Iwamoto, Takuya, Matsumoto, Toshihiko, Hidaka, Isao, Ishikawa, Tsuyoshi, Uchida, Koichi, Tani, Kenji, Sakaida, Isao
Publicado 2016